Insulin Management
Diabetes: Medtronic and Sanofi ally on new drug-device combinations
Diabetes: Bionic pancreas tech may give Type I diabetics some freedom, study finds
Diabetes: New warnings for Medtronic’s Paradigm insulin pumps
Australian healthcare regulators issued renewed warnings to patients using Medtronic’s (NYSE:MDT) Paradigm insulin pumps, cautioning that an accidental button-press may result in a potentially dangerous overdose.
CeQur gets new CEO from Becton Dickinson | Personnel Moves
Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.
Lawrence has spent more than 25 years in the medical device industry, most recently as vice president of the insulin injection business at Becton, Dickinson’s (NYSE:BDX) diabetes arm.